Skip to content

Napp Pharmaceuticals v Dr Reddy’s Laboratories (UK) Limited & Sandoz Limited (BuTrans and Butec)

Following the appeal hearing in this case in August, the Court of Appeal dismissed Napp’s appeal and upheld the decision of Arnold J that the products of Dr Reddys and Sandoz Ltd did not fall within the relevant claims of the patent in suit and therefore there was no threat by either of the defendants to infringe the patent. The Court of Appeal gave its reasons for this decision on 1 November.



1 Nov 2019